Navigation Links
A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction
Date:3/8/2013

ation therapy is difficult to manage well, even if closely monitored, particularly if they take medicines or foods that affect these enzymes.  Recent data shows that these drug metabolizing enzymes are down regulated in patients with chronic renal dysfunction or failure which may explain the sub-optimal anti-coagulation control with warfarin or with the novel non-monitored OACs in these patients.

Monitoring the effectiveness of warfarin in many cases requires patients to travel frequently to a local clinic to have their anticoagulation status checked and, if needed, doses adjusted.  Recently, perhaps due to reimbursement by healthcare providers, there has been an increase in patient self-monitoring and management of anticoagulation therapy that is currently only applicable to VKOR inhibitors such as tecarfarin. Ultimately, this system could provide many patients with a cost-effective management of anticoagulation therapy with a better patient compliance than with new oral non-monitored OACs.

About Tecarfarin

Tecarfarin (ATI-5923) is potentially a best-in-class orally active vitamin K epoxide (VKOR) inhibitor that was specifically designed to avoid CYP2C9 dependent metabolism and to avoid transport by P-gp. This may mean tecarfarin will need less monitoring than warfarin, potentially resulting in better patient compliance if used together with widely available self-monitoring systems. Unlike the novel non-monitored OACs, tecarfarin has an antidote, vitamin K that is readily available and can be used to rapidly reverse the anticoagulation effect of tecarfarin in an emergency. If approved, tecarfarin could become a superior anticoagulation management solution to warfarin.

About Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area based clinical stage biopharmaceutical company focused on the development of novel drugs for highly unmet need. The company has 3 programs in mid - to late - clinical stage developm
'/>"/>

SOURCE Armetheon, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
3. Upcoming Presentations on Global Market Access Issues and Trends in Health Economics and Outcomes Research at ISPOR 2012 by Novel Health Strategies
4. Scripps Doctors Study Novel New Device to Diagnose Irregular Heart Beat
5. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
8. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
9. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
10. OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
11. CSL Behring Receives FDA Orphan Drug Designation for rIX-FP, a Novel Therapy in Development to Treat Congenital Factor IX Deficiency (Hemophilia B)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... LONDON , March 26, 2015 ... release, please scroll to bottom . Investor-Edge ... (NASDAQ: MYL ), Salix Pharmaceuticals Ltd (NASDAQ: ... Inc. (NASDAQ: VVUS ), and Akorn Inc. (NASDAQ: ... be accessed at http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets ...
(Date:3/26/2015)... , Kalifornien, 26. März 2015 /PRNewswire/ ... Cellworld 2015, die sich speziell an Innovatoren, ... an. Die zweitägige Konferenz für ... September 2015 im Hyatt Regency in ... In diesem Forum werden führende Akteure der ...
(Date:3/26/2015)... , Califórnia, 26 de março de 2015 ... evento que é projetado especificamente para os inovadores, visionários ... de dois dias, apenas por convite, será realizada no ... em 21 e 22 de setembro de 2015. ... para discutir o futuro da fabricação de produtos biofarmacêuticos ...
Breaking Medicine Technology:Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2
... California and AMSTERDAM, July 21, 2011 , ... in,molecular cancer diagnostics, announced today that, together with,thought-leading ... has launched the RATHER (Rational Therapy for,Breast Cancer) ... will collectively receive nearly €12,million in funding from ...
... MEADVILLE, Pa., July 21, 2011 C&J Industries announced today the ... expansion. With these 2 Phases complete, C&J now has three Class ... Molding presses. These presses range in size from 20 Ton, ... the machines are Toshiba all-electric presses. C&J has also ...
Cached Medicine Technology:Agendia Receives €1.27 Million in Funding from the EU's Seventh Framework Programme 2Agendia Receives €1.27 Million in Funding from the EU's Seventh Framework Programme 3C&J Industries Completes Phases I and II of Building Expansion 2
(Date:3/26/2015)... “The SWEET Act is an important step ... available and help parents who are working to reduce sugar ... approach to support public health, and we will continue to ... health of all families,” said Dr. Jane Delgado President and ... introduction of the Sugar-Sweetened Beverage Tax (SWEET) Act by Congresswoman ...
(Date:3/26/2015)... 26, 2015 The Life Support ... to Hyperbaric Medicine” course, which is accredited by ... and the National Board of Diving & Hyperbaric ... course 4 times a year at several of ... tri-state region; registration is available on-line at: ...
(Date:3/26/2015)... The National League for Nursing, and ... has announced its partnership with Questionmark®, a supplier ... to accurately and securely measure knowledge, skills, and ... Questionmark’s state-of-the-art software and a custom-built portal, ... of the seventy-five to one hundred thousand exams ...
(Date:3/26/2015)... 26, 2015 In preparation for the ... Revolution, founded by Samir Becic, has issued “report ... personal health and fitness, as well as their promotion ... list includes Sen. Ted Cruz, who has officially announced ... all other politicians who have shown interest in running ...
(Date:3/26/2015)... 26, 2015 Zane Benefits, the leader ... a new eBook, “The Comprehensive Guide To Interviewing For ... is the most important aspect of the hiring process. ... hiring the right way, possibly resulting in thousands of ... arduous undertaking, yet it’s essential to the success of ...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:NLN Testing Services Announces Improved Delivery and Analytics Software and Newly Developed and Revised Exams 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:Zane Benefits Announces: New eBook: The Comprehensive Guide To Interviewing For Your Small Business 2
... energy drinks even those containing no alcohol may ... researchers at the University of Maryland School of Public Health ... a new online commentary in the Journal of the ... consumer action, education by health providers, voluntary disclosures by manufacturers ...
... FAIRFAX, Va.The Journal of Vascular and Interventional ... Society of Interventional Radiologyannounced several major changes for ... this minimally invasive medical specialty and its lead ... focuses on critical and cutting-edge medical, minimally invasive, ...
... successful application of the technology used in home devices ... anticancer drugs like tamoxifen and paclitaxel dissolve more easily ... disease. The process, described in ACS, journal, Langmuir, can ... potential for improving the performance of dyes, paints, rust-proofing ...
... fruit flies. And it,s not just because they breed ... genetics and developmental biology by breeding and studying fruit flies ... most important research animals because they reproduce quickly and, well, ... share many genes and proteins with humans. Now there,s ...
... of nurses and nursing students may have substance abuse and ... - and protecting public safety - is support and treatment, ... in the February issue of the Journal of Clinical ... that could be built into alternative-to-dismissal (ATD) strategies after reviewing ...
... By Dennis Thompson HealthDay Reporter , TUESDAY, ... is strongly associated with stroke in people aged 65 and ... that for every 10 decibels or more of road noise, ... percent. For people younger than 65, that did not ...
Cached Medicine News:Health News:Non-alcoholic energy drinks may pose 'high' health risks 2Health News:Journal of Vascular and Interventional Radiology debuts new look, reflects global impact 2Health News:Journal of Vascular and Interventional Radiology debuts new look, reflects global impact 3Health News:Zebrafish popular with researchers 2Health News:Support not punishment is the key to tackling substance abuse and addiction among nurses 2Health News:Support not punishment is the key to tackling substance abuse and addiction among nurses 3Health News:Loud Road Noise Linked to Stroke in Older Adults 2Health News:Loud Road Noise Linked to Stroke in Older Adults 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: